← Back to Search

Procedure

EMR Feasibility for Atrial Fibrillation

N/A
Waitlist Available
Led By Raul Mitrani, MD
Research Sponsored by Jeffrey Goldberger
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial is testing a new way to find and fix areas in the heart that are causing atrial fibrillation. Ten subjects will have their atrial fibrillation mapped using the new technology, and then the areas causing the atrial fibrillation will be ablated. The goal is to show that this technology can be used to find the areas causing atrial fibrillation and to show that ablation of these areas can improve atrial fibrillation.

Eligible Conditions
  • Atrial Fibrillation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Real-time Electrogram Morphology Recurrence (EMR) Mapping Feasibility
Secondary outcome measures
Ablation Acute Effects
Number of Participants With Treatment Emergent Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: EMR FeasibilityExperimental Treatment1 Intervention
In this feasibility study, all ten patients will undergo EMR mapping which will be used to guide ablation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Electrogram Morphology Mapping (EMR)
2017
N/A
~10

Find a Location

Who is running the clinical trial?

Jeffrey GoldbergerLead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,831 Previous Clinical Trials
47,303,744 Total Patients Enrolled
45 Trials studying Atrial Fibrillation
539,583 Patients Enrolled for Atrial Fibrillation
Raul Mitrani, MDPrincipal InvestigatorUniversity of Miami

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation
Jeffrey Goldberger 2017. "Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03082963.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top